Adherence to etanercept therapy in rheumatoid arthritis patients during 3 years of follow-up

Autor: Merel J l'Ami, Michael T. Nurmohamed, Gertjan Wolbink, C. Krieckaert, R. C. F. Hebing, A W R van Kuijk, Erik H Vogelzang, J. W. F. Kruijff

Publikováno v: PLoS ONE, Vol 13, Iss 10, p e0205125 (2018)
PLoS ONE, 13(10):e0205125. Public Library of Science
PLoS ONE
PLoS ONE, 13(10). Public Library of Science
Vogelzang, E H, Hebing, R C F, Nurmohamed, M T, van Kuijk, A W R, Kruijff, J W F, l'Ami, M J, Krieckaert, C L M & Wolbink, G 2018, ' Adherence to etanercept therapy in rheumatoid arthritis patients during 3 years of follow-up ', PLoS ONE, vol. 13, no. 10, pp. e0205125 . https://doi.org/10.1371/journal.pone.0205125

OBJECTIVES: To determine the percentage non-adherence to etanercept in patients with rheumatoid arthritis during three years of follow-up.METHODS: During study visits in this prospective cohort study, blood samples were taken to determine serum etane

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18dd151d67794e717462009573732780
https://doi.org/10.1371/journal.pone.0205125